The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice

Cellular Physiology and Biochemistry

Volumn 19, Issue 1-4, 2007, Pages 137-152

  Bachmeier, Beatrice E ^a   Nerlich, Andreas G ^b   Iancu, Cristina M ^a,c   Cilli, Michele ^d   Schleicher, Erwin ^e   Vené, Roberta ^f   Dell'Eva, Raffaella ^f   Jochum, Marianne ^a   Albini, Adriana ^f   Pfeffer, Ulrich ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b KLINIKUM BOGENHAUSEN   (Germany)

^c UNIVERSITY OF BUCHAREST   (Romania)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f IRCCS MULTIMEDICA   (Italy)

Author keywords

Apoptosis; Breast Cancer; Matrix Metalloproteinase; Metastasis in vivo; NF B

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALIA; MUS;

EID: 33847066381     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099202     Document Type: Article

References (71)

1. Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med 1991;57:1-7.
2. Nagabhushan M, Bhide SV: Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992;11:192-198.
3. Kuo ML, Huang TS, Lin JK: Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1996;1317:95-100.
4. Chen H, Zhang ZS, Zhang YL, Zhou DY: Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 1999;19:3675-3680.
5. Mehta K, Pantazis P, McQueen T, Aggarwal BB: Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 1997;8:470-481.
6. Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, Zhu BT, Newmark H, Ho CT: Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 1998;19:1697-1700.
7. Limtrakul P, Lipigorngoson S, Namwong O, Apisariyakul A, Dunn FW: Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 1997;116:197-203.
8. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS: Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999;59:597-601.
9. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL: Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 2000;21:331-335.
10. Bharti AC, Donato N, Singh S, Aggarwal BB: Curcumin (diferuloylmethane) downregulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003;101:1053-1062.
11. Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R: Nuclear factorkappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 2004;101:2351-2362.
12. Singh S, Aggarwal BB: Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995;270:24995-25000.
13. Garg A, Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002;16:1053-1068.
14. Wu JT, Kral JG: The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res 2005;123:158-169.
15. Stetler-Stevenson WG, Yu AE: Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 2001;11:143-152.
16. Bachmeier BE, Nerlich AG, Boukamp P, Lichtinghagen R, Tschesche H, Fritz H, Fink E: Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1. Biol Chem 2000;381:509-516.
17. Bachmeier BE, Boukamp P, Lichtinghagen R, Fusenig NE, Fink E: Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem 2000;381:497-507.
18. Meade-Tollin LC, Boukamp P, Fusenig NE, Bowen CP, Tsang TC, Bowden GT: Differential expression of matrix metalloproteinases in activated c-ras-Hatransfected immortalized human keratinocytes. Br J Cancer 1998;77:724-730.
19. Bachmeier BE, Nerlich AG, Lichtinghagen R, Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. Anticancer Res 2001;21:3821-3828.
20. Benbow U, Schoenermark MP, Orndorff KA, Givan AL, Brinckerhoff CE: Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid. Clin Exp Metastasis 1999;17:231-238.
21. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T, Lebrun A, Dejonghe MJ, Huet G: Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 2000;18:171-178.
22. Vincenti MP: The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 2001;151:121-148.
23. Westermarck J, Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781-792.
24. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH: A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 2003;369:485-496.
25. Bond M, Chase AJ, Baker AH, Newby AC: Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 2001;50:556-565.
26. Vincenti MP, Coon CI, Brinckerhoff CE: Nuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis Rheum 1998;41:1987-1994.
27. Vincenti MP, Brinckerhoff CE: Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of genespecific transcription factors. Arthritis Res 2002;4:157-164.
28. Cailleau R, Olive M, Cruciger QV: Longterm human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978;14:911-915.
29. Cailleau R, Young R, Olive M, Reeves WJ, Jr.: Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 1974;53:661-674.
30. Zhang RD, Fidler IJ, Price JE: Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991;11:204-215.
31. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156-159.
32. Albini A: Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms. Pathol Oncol Res 1998;4:230-241.
33. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-3245.
34. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR: Basement membrane complexes with biological activity. Biochemistry 1986;25:312-318.
35. Netzker R, Weigert C, Brand K: Role of the stimulatory proteins Sp1 and Sp3 in the regulation of transcription of the rat pyruvate kinase M gene. Eur J Biochem 1997;245:174-181.
36. Bachmeier BE, Nerlich AG: Immunohistochemical pattern of cytokeratins and MMPs in human keratinocyte cell lines of different biological behaviour. Int J Oncol 2002;20:495-499.
37. Manna SK, Aggarwal BB: Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptormediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13. J Biol Chem 1998;273:33333-33341.
38. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Jr., Sledge GW, Jr.: Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997;17:3629-3639.
39. Chen Z, Smith CW, Kiel D, Van Waes C: Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction. Clin Exp Metastasis 1997;15:527-537.
40. Noel A, Kebers F, Maquoi E, Foidart JM: Cell-cell and cell-matrix interactions during breast cancer progression. Curr Top Pathol 1999;93:183-193.
41. Hunter KW: Host genetics and tumour metastasis. Br J Cancer 2004;90:752-755.
42. Philip M, Rowley DA, Schreiber H: Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004;14:433-439.
43. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K: Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 1994;56:554-558.
44. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-6866.
45. Yu G, Rux AH, Ma P, Bdeir K, Sachais BS: Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood 2005;105:3545-3551.
46. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD: NFkappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A 2004;101:10137-10142.
47. Pfeffer U, Ferrari N, Dell'Eva R, Indraccolo S, Morini M, Noonan DM, Albini A: Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: Microarray gene expression analyses. Mutat Res 2005.
48. Park AM, Dong Z: Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol 2003;36:66-77.
49. Shao ZM, Shen ZZ, Liu CH, Sartippour MR, Go VL, Heber D, Nguyen M: Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 2002;98:234-240.
50. Hong JH, Ahn KS, Bae E, Jeon SS, Choi HY: The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 2006;9:147-152.
51. Menon LG, Kuttan R, Kuttan G: Antimetastatic activity of curcumin and catechin. Cancer Lett 1999;141:159-165.
52. Menon LG, Kuttan R, Kuttan G: Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 1995;95:221-225.
53. Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H, Saiki I: Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 2003;65:250-258.
54. Ichiki K, Mitani N, Doki Y, Hara H, Misaki T, Saiki I: Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer. Clin Exp Metastasis 2000;18:539-545.
55. Hahm ER, Gho YS, Park S, Park C, Kim KW, Yang CH: Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun 2004;321:337-344.
56. Banerji A, Chakrabarti J, Mitra A, Chatterjee A: Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett 2004;211:235-242.
57. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 2006;69:195-206.
58. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M: Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NFkappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol 2001;281:L1444-L1452.
59. Philip S, Bulbule A, Kundu GC: Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Glycoconj J 2004;21:429-441.
60. Divya CS, Pillai MR: Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 2006;45:320-332.
61. Park CH, Lee JH, Yang CH: Curcumin derivatives inhibit the formation of Jun- Fos-DNA complex independently of their conserved cysteine residues. J Biochem Mol Biol 2005;38:474-480.
62. Benbow U, Brinckerhoff CE: The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 1997;15:519-526.
63. Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR: Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 1996;73:1401-1408.
64. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J, Saarialho-Kere UK: Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999;80:733-743.
65. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-462.
66. Tetu B, Brisson J, Lapointe H, Bernard P: Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer. Hum Pathol 1998;29:979-985.
67. Bachmeier BE, Rohrbach H, De Waal J, Jochum M, Nerlich AG: Enhanced expression and activation of major matrix metalloproteinases in distinct topographic areas of invasive breast carcinomas. Int J Oncol 2005;26:1203-1207.
68. Bachmeier BE, Vene R, Iancu CM, Pfeffer U, Mayer B, Noonan D, Albini A, Jochum M, Nerlich AG: Transcriptional control of cell density dependent regulation of matrix metalloproteinase and TIMP expression in breast cancer cell lines. Thromb Haemost 2005;93:761-769.
69. Bachmeier BE, Albini A, Vene R, Benelli R, Noonan D, Weigert C, Weiler C, Lichtinghagen R, Jochum M, Nerlich AG: Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines. Exp Cell Res 2005;305:83-98.
70. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 2005;11:7490-7498.
71. Commandeur JN, Vermeulen NP: Cytotoxicity and cytoprotective activities of natural compounds. The case of curcumin. Xenobiotica 1996;26:667-680.